Explore the latest trends and developments in the in vitro diagnostic (IVD) market with Kalorama Information’s comprehensive report, In Vitro Diagnostic (IVD) Trends and Market Update: March 2024. Gain insights into key growth segments, industry trends, and emerging technologies shaping the future of IVD.
The report offers updated data analysis based on Kalorama Information’s annual flagship report, The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition (published August 2023).
Diagnostic testing has become a fundamental aspect of healthcare, aiding physicians in diagnosing conditions and determining treatments. Factors such as new products, changes in global health spending, regulatory shifts, and disease trends contribute to a constantly changing market, yet one that remains resilient.
Key growing segments attracting industry attention include next-generation sequencing (NGS), personalized medicine, and mass spectrometry. Immunochemistry, point-of-care (POC) testing, and molecular diagnostics are also of significant interest, expected to play a crucial role in the future of IVD. The IVD market remains dynamic, characterized by constant innovations.
Key Features:
- Analysis of factors driving growth in the IVD market
- Examination of major trends affecting the market
- Insights into product trends and new developments
- Coverage of key segments including NGS, personalized medicine, and mass spectrometry
Highlighted Trends:
- Multiplex disease testing
- Digital diagnostics combining data and analytics
- Advancements in AI technologies
- Growth in rapid and POC testing
Methodology:
- Utilization of the latest available data
- Expert analysis by Kalorama Information’s authors
- Commitment to excellence in market analysis
Scope:
- Focus on core diagnostic segments experiencing growth
- Analysis of new products, global health spending changes, regulatory shifts, and disease trends
Market Update: Stay informed with the most current insights into the IVD market with In Vitro Diagnostic (IVD) Trends and Market Update: March 2024.
For further details and to purchase directly, please contact us.
Sample Report: A sample is available as a PDF upon request.
Table: Global In Vitro Diagnostic Market, by Segment, YoY Growth, 2022-2023 (%)
| Global IVD Market | 2022-2023 YoY % |
| Clinical Chemistry | XX% |
| Immunoassays – non isotopic | |
| Infectious disease | XX% |
| Other immunos | XX% |
| Blood bank screening | XX% |
| Drugs of Abuse | XX% |
| Diabetes HbA1c, lab | XX% |
| Hematology – Core Lab | XX% |
| Microbiology (ID/AST) | XX% |
| Microbiology (molecular) | XX% |
| Coagulation (PT/INR) | XX% |
| Histology/cytology | XX% |
| d-dimer | XX% |
| Nucleic acid assays/genetic tests | XX% |
| Blood grouping/typing | XX% |
| Blood bank molecular – NAT Screens | XX% |
| POC, OTC diabetes | XX% |
| POC, OTC other | XX% |
| POC, professional/hospital | XX% |
| IVD Total | XX% |
Re-evaluated March 2024
Source: Kalorama Information
